From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus

Daniel J. Rader(University of Pennsylvania), Ludmila Prokunina‐Olsson(National Cancer Institute), Carlos R. Morales(McGill University), Kenechi G. Ejebe(Broad Institute), James P. Pirruccello(University of California, San Francisco), Vera M. Ruda(Boston Biomedical Research Institute), Noemi E Lee(Harvard University), Alanna Strong(Children's Hospital of Philadelphia), Hui Li(Sun Yat-sen University), Timothy Racie(Alnylam Pharmaceuticals (United States)), Sekar Kathiresan(Broad Institute), Tim Ahfeldt(Allen Institute for Brain Science), Michael C. Phillips(Translational Therapeutics (United States)), Eric E. Schadt(Program for Appropriate Technology in Health), Nicolas Kuperwasser(Harvard University), Jennifer L. Hall(American Heart Association), Ronald M. Krauss(University of California System), Marju Orho‐Melander(Lund University), Maria Frank-Kamenetsky(Alnylam Pharmaceuticals (United States)), Olle Melander(Lund University), Xiaoyu Li(Academy of Military Medical Sciences), William Cantley(Alnylam Pharmaceuticals (United States)), Katherine V. Sachs(Translational Therapeutics (United States)), Brian Muchmore(National Institutes of Health), Sissel Lund‐Katz(Children's Hospital of Philadelphia), Victor Koteliansky(Centre National de la Recherche Scientifique), Jamie Wong(Alnylam Pharmaceuticals (United States)), Chad A. Cowan(Harvard University), Kevin Fitzgerald(Epsilon Systems (United States))
Nature
August 1, 2010
Cited by 1,197


Related Papers